E. Lin
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- BRCA gene mutations in cancer
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in ⓘ
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Oncology 16
- Co-authors
- Ming Guo (7 shared papers)Nour Sneige (6 shared papers)L. Jeffrey Medeiros (3 shared papers)C. Cameron Yin (2 shared papers)Pei Lin (2 shared papers)Patrick A. Lennon (1 shared paper)Luis Fayad (1 shared paper)Roberto N. Miranda (1 shared paper)
- Journals
- Cancer (5 papers)Modern Pathology (4 papers)Journal of Clinical Oncology (4 papers)CardioVascular and Interventional Radiology (3 papers)Journal of Vascular and Interventional Radiology (2 papers)
- Partner nations
- United StatesTaiwanGermany
In The Last Decade
E. Lin
44 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 96
- Genetics 297
- Hepatology 200
- Oncology 590
- Cancer Research 270
- Pathology and Forensic Medicine 304
Countries citing papers authored by E. Lin
This map shows the geographic impact of E. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lin more than expected).
Fields of papers citing papers by E. Lin
This network shows the impact of papers produced by E. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lin. The network helps show where E. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 239 | |
| 2 | 2011 | 196 | |
| 3 | 2009 | 159 | |
| 4 | 2011 | 105 | |
| 5 | 2011 | 84 | |
| 6 | 2007 | 77 | |
| 7 | 2012 | 75 | |
| 8 | 2009 | 74 | |
| 9 | 2009 | 59 | |
| 10 | 2006 | 55 | |
| 11 | 2009 | 54 | |
| 12 | 2011 | 49 | |
| 13 | 2009 | 45 | |
| 14 | 2010 | 42 | |
| 15 | 2011 | 41 | |
| 16 | 2011 | 34 | |
| 17 | 2008 | 26 | |
| 18 | 2018 | 25 | |
| 19 | 2009 | 23 | |
| 20 | 2005 | 21 |
About E. Lin
E. Lin is a scholar working on Hepatology, Oncology, Radiology, Nuclear Medicine and Imaging, Hematology and Epidemiology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cervical Cancer and HPV Research (7 papers), MRI in cancer diagnosis (6 papers), Acute Myeloid Leukemia Research (4 papers), Advanced X-ray and CT Imaging (4 papers), Renal cell carcinoma treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Genetics (297 citations), Hepatology (200 citations), Oncology (590 citations), Cancer Research (270 citations) and Pathology and Forensic Medicine (304 citations). E. Lin has collaborated with scholars based in United States, Taiwan and Germany. Frequent co-authors include Ming Guo, Nour Sneige, L. Jeffrey Medeiros, C. Cameron Yin, Pei Lin, Patrick A. Lennon, Luis Fayad, Roberto N. Miranda, Shaoying Li and Kenneth Aldape. Their work appears in journals such as Cancer, Modern Pathology, Journal of Clinical Oncology, CardioVascular and Interventional Radiology and Journal of Vascular and Interventional Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.